Dangerous Prescription Drugs Archives - Page 2 of 16

FDA: Popular Drugs Gabapentin and Pregabalin Linked to Serious Breathing Problems

A pair of popular drugs used to treat a wide range of common conditions could put people with certain respiratory conditions at risk of…

Terry Turner March 24, 2020
What Zantac Recall Could Cost Drugmakers, Consumers

Some drugmakers that issued voluntary recalls for Zantac and its generic form, ranitidine, for potential contamination with the carcinogen NDMA may rack up…

Michelle Llamas December 9, 2019
Filmmaker Blames Cipro Antibiotic for ‘Mystery Illness’

On this episode of the Drugwatch Podcast, our guest is filmmaker and artist Michelle Polacinski. After taking the fluoroquinolone antibiotic Cipro for a…

Michelle Llamas November 18, 2019
FDA Announces Generic Zantac Recalls Amid Cancer Concerns

Some generic versions of the heartburn drug Zantac are being recalled in the United States because they may contain low levels of N-nitrosodimethylamine (NDMA),…

Emily Miller October 2, 2019
Cipro, Levaquin Elevate Risk for Aortic Aneurysm, Researchers Say

Exposure to Cipro, Levaquin and other fluoroquinolones, such as Avelox, is “highly associated with risk for aortic aneurysm and dissection,” researchers found. Aortic…

Kristin Compton September 18, 2018
Valsartan Recalls Grow, Affect Millions of Patients

More than 4,500 Veterans Administration patients are among potentially millions of Americans whose blood-pressure medication was tainted with a probable cancer-causing chemical. The worldwide…

Elaine Silvestrini August 9, 2018

Testing Positive for COVID-19: It Felt Like I Had a Compression Belt Around My Chest

COVID-19: A Consumer’s Guide to the Coronavirus

Supreme Court Won’t Hear Johnson & Johnson Appeal of $2 Billion Talc Ovarian Cancer Lawsuit

Erika Sward of American Lung Association Reveals the Dangers of Vaping and IQOS

FDA: Popular Drugs Gabapentin and Pregabalin Linked to Serious Breathing Problems

What Zantac Recall Could Cost Drugmakers, Consumers

Filmmaker Blames Cipro Antibiotic for ‘Mystery Illness’

FDA Announces Generic Zantac Recalls Amid Cancer Concerns

Cipro, Levaquin Elevate Risk for Aortic Aneurysm, Researchers Say

Valsartan Recalls Grow, Affect Millions of Patients